“…This eventually led me to publish a paper in 2012 with a unified hypothesis on the etiology of IBD,[2] in which I included some evidences collected at that time, such as the remarkable increase of IBD in Alberta of Canada since the early 1990s, in Brisbane of Australia since the middle 1990s, in North California of the United States since the late 1990s, and in southeastern Norway since the middle 2000s, shortly after the approval of sucralose in Canada in 1991, in Australia in 1993, in the United States in 1998, and by the European Union in 2004. After the publication of that paper, more evidences are accumulating, such as the recent study showing a remarkable increase of pediatric IBD, also mainly CD, in Singapore since the beginning of this new millennium,[3] which happened again shortly after the approval of sucralose in Singapore in 1998. As Saudi Arabia approved sucralose around 2000, I recommend checking out the possible link between sucralose and the recent emergence of IBD in this country.…”